carbostyril has been researched along with Kidney Failure, Chronic in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (66.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benchitrit, J; Drüeke, TB; Edelman, A; Galmiche, A; Guerrera, IC; Guillonneau, F; Ivanovski, O; Joki, N; Lacour, B; Lucas, A; Maizel, J; Marçon, F; Massy, ZA; Nguyen-Khoa, T; Nikolov, IG; Phan, O | 1 |
| Clark, MR; Liarski, VM; Trotter, K | 1 |
| Basic-Jukic, N; Juric, I; Kes, P; Racki, S | 1 |
| Chiang, CP; Tzeng, NS | 1 |
| Aragona, M | 1 |
| Aoki, N; Kouda, Y; Usuda, Y; Yoshikawa, H | 1 |
| Dvoretskiĭ, LI; Iakovlev, SV; Izotova, GN; Kolendo, SE; Miagkov, AV; Shvyreva, GS; Vorob'ev, PA | 1 |
| Bruno, R; Dhib, M; Etienne, I; Fillastre, JP; Gay, G; Guimart, C; Le Roux, Y; Montay, G; Schott, D; Vivier, N | 1 |
| Kanno, Y; Okada, H; Saruta, T; Suzuki, H; Yamamura, Y | 1 |
| Imbimbo, BP; Mant, TG; Morrison, PJ; Perry, G; Sacks, S; Wise, R; Woodcook, J | 1 |
| Miura, Y; Nakano, H; Nakayama, M; Suzuki, S; Tuchida, H; Yamada, K; Yoshida, S | 1 |
| Miura, Y; Nakano, H; Nakayama, M; Suzuki, S; Tsuchida, H; Yamada, K; Yoshida, S | 1 |
| Blum, RA | 1 |
| Borsa-Lebas, F; Dhib, M; Fillastre, JP; Humbert, G; Leroy, A; Moulin, B | 1 |
| Fillastre, JP; Humbert, G; Leroy, A | 1 |
3 review(s) available for carbostyril and Kidney Failure, Chronic
| Article | Year |
|---|---|
Overview of pathophysiology and treatment of human lupus nephritis.
Topics: Abatacept; Antibodies, Monoclonal, Humanized; Autoantibodies; Biopsy; Cyclophosphamide; Dendritic Cells; Disease Progression; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammation; Interferon Type I; Kidney Failure, Chronic; Lupus Nephritis; Maintenance Chemotherapy; Mycophenolic Acid; Prognosis; Quinolones; Recombinant Fusion Proteins; Remission Induction; Ribonucleosides; Severity of Illness Index; T-Lymphocytes, Helper-Inducer; Treatment Outcome; Vimentin | 2016 |
Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
Topics: Anti-Infective Agents; Creatinine; Fluoroquinolones; Humans; Kidney Failure, Chronic; Meta-Analysis as Topic; Metabolic Clearance Rate; Quinolones | 1992 |
Pharmacokinetics of quinolones in renal insufficiency.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Glomerular Filtration Rate; Half-Life; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1990 |
12 other study(ies) available for carbostyril and Kidney Failure, Chronic
| Article | Year |
|---|---|
Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice.
Topics: Animals; Aorta; Apolipoproteins E; Apoptosis; Atherosclerosis; Blood Proteins; Body Weight; Collagen Type I; Enzyme Inhibitors; Farnesyltranstransferase; Female; Kidney Failure, Chronic; Liver; Macrophages; Mevalonic Acid; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Prenylation; Quinolones; Random Allocation; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tyrosine; Uremia; Vascular Calcification | 2013 |
Spontaneous tendon ruptures in patients with end-stage renal disease.
Topics: Female; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Quinolones; Renal Replacement Therapy; Rupture, Spontaneous; Steroids; Tendon Injuries | 2009 |
Delusional parasitosis in a patient with brain atrophy and renal failure treated with aripiprazole: case report.
Topics: Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Delusions; Humans; Kidney Failure, Chronic; Male; Piperazines; Quinolones; Renal Dialysis; Treatment Outcome | 2010 |
Tolerability and efficacy of aripiprazole in a case of psychotic anorexia nervosa comorbid with epilepsy and chronic renal failure.
Topics: Adult; Anorexia Nervosa; Antipsychotic Agents; Aripiprazole; Comorbidity; Epilepsy; Female; Humans; Kidney Failure, Chronic; Piperazines; Psychotic Disorders; Quinolones; Treatment Outcome | 2007 |
[Pharmacokinetic study of sparfloxacin in patients receiving regular hemodialysis].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Fluoroquinolones; Half-Life; Humans; Kidney Failure, Chronic; Male; Middle Aged; Quinolones; Renal Dialysis | 1995 |
[Lomefloxacin pharmacokinetics in patients in the terminal stage of chronic renal insufficiency, undergoing treatment with programmed hemodialysis].
Topics: Anti-Infective Agents; Combined Modality Therapy; Fluoroquinolones; Humans; Kidney Failure, Chronic; Quinolones; Renal Dialysis | 1995 |
Pharmacokinetics of sparfloxacin in patients with renal impairment.
Topics: Adult; Aged; Anti-Infective Agents; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Half-Life; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Quinolones; Spectrophotometry, Ultraviolet | 1994 |
Effects of vasopressin V1 and V2 receptor antagonists on progressive renal failure in rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Kidney; Kidney Failure, Chronic; Male; Piperidines; Quinolones; Rats; Rats, Wistar; Urine | 1994 |
Pharmacokinetics of rufloxacin in patients with impaired renal function.
Topics: Adult; Anti-Infective Agents; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Glomerular Filtration Rate; Half-Life; Humans; Kidney Failure, Chronic; Male; Middle Aged; Quinolones; Regression Analysis; Renal Dialysis | 1993 |
A lack of anti-hypertensive effect of an orally effective V1 receptor antagonist, OPC-21268, in end-stage renal disease.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Female; Humans; Hypertension, Renal; Kidney Failure, Chronic; Male; Middle Aged; Piperidines; Quinolones | 1993 |
The effect of OPC-21268, an oral, nonpeptide arginine vasopressin V1 receptor antagonist, on a patient with congestive heart failure.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Diabetes Mellitus, Type 2; Female; Heart Failure; Heart Rate; Humans; Kidney Failure, Chronic; Piperidines; Quinolones | 1993 |
Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Female; Fluoroquinolones; Half-Life; Humans; Kidney Failure, Chronic; Male; Middle Aged; Quinolones; Reference Values; Renal Dialysis | 1990 |